Catalyst Wire Dossier Catalyst Wire Dossier

Oral hormone replacement therapy formulations (three formulations)

· Novo Nordisk A/S
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Oral hormone replacement therapy formulations (three formulations), covering 2016-01-15 to 2016-01-15. Get the full timeline:

Most recent: Clinical Trial Update: Bioavailability of Three Oral Formulations for Hormone Replacement Therapy in Postmenopausal Women [Phase 1]

See pricing